Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov 22:10:1082883.
doi: 10.3389/fbioe.2022.1082883. eCollection 2022.

Editorial: Gene therapy 2.0: Biotechnology for circuit engineering and complex therapeutic approaches

Luís Quintino  1 , Luís Pereira de Almeida  2 , Cecilia Lundberg  1
Affiliations
Editorial

Editorial: Gene therapy 2.0: Biotechnology for circuit engineering and complex therapeutic approaches

Luís Quintino et al. Front Bioeng Biotechnol. .
No abstract available

Keywords: RNA therapy; aav; gene expression; gene therapy; trans splicing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Gene therapy 2.0: Biotechnology for circuit engineering and complex therapeutic approaches

References

    1. ASGCT ASGCT gene therapy basics. Available at: https://patienteducation.asgct.org/gene-therapy-101/gene-therapy-basics (Accessed October 26, 2022).
    1. Becker J., Fakhiri J., Grimm D. (2022). Fantastic AAV gene therapy vectors and how to find them—random diversification, rational design and machine learning. Pathogens 11, 756. 10.3390/pathogens11070756 - DOI - PMC - PubMed
    1. Blair H. A. (2022). Onasemnogene abeparvovec: A review in spinal muscular atrophy. Cns Drugs 36, 995–1005. 10.1007/s40263-022-00941-1 - DOI - PubMed
    1. Challis R. C., Kumar S. R., Chen X., Goertsen D., Coughlin G. M., Hori A. M., et al. (2022). Adeno-associated virus toolkit to target diverse brain cells. Annu. Rev. Neurosci. 45, 447–469. 10.1146/annurev-neuro-111020-100834 - DOI - PubMed
    1. Ertl H. C. J. (2022). Immunogenicity and toxicity of AAV gene therapy. Front. Immunol. 13, 975803. 10.3389/fimmu.2022.975803 - DOI - PMC - PubMed

Publication types

LinkOut - more resources